TransCelerate has led the way in conducting research to help sponsors and CROs identify and facilitate the implementation of solutions to drive efficient delivery of new medicines. The organization states that the adoption of Risk Assessment Categorization (RACT) in clinical trials is instrumental in the identification of potential risk factors that may impact studies, and, therefore, delay or halt regulatory submission.…